Diabetes and congenital heart defects: A systematic review, meta-analysis, and modeling project

American Journal of Preventive Medicine

Volumn 48, Issue 2, 2015, Pages 195-204

  Simeone, Regina M ^a,d   Devine, Owen J ^a   Marcinkevage, Jessica A ^a,d   Gilboa, Suzanne M ^a   Razzaghi, Hilda ^a,d   Bardenheier, Barbara H ^b   Sharma, Andrea J ^b,c   Honein, Margaret A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c Maryland   (United States)

^d OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA COARCTATION; ATRIOVENTRICULAR SEPTAL DEFECT; CASE CONTROL STUDY; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; FALLOT TETRALOGY; GLYCEMIC CONTROL; GREAT VESSELS TRANSPOSITION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFORMATION RETRIEVAL; LIVE BIRTH; MATERNAL CARE; MATERNAL DIABETES MELLITUS; META ANALYSIS (TOPIC); MONTE CARLO METHOD; PREGNANCY OUTCOME; PREVALENCE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEFECTS, CONGENITAL; META ANALYSIS; METABOLISM; PREGNANCY; PREGNANCY DIABETES MELLITUS; STATISTICAL MODEL;

GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84921391797     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.09.002     Document Type: Article

References (64)

1. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008;153(6):807-13.
2. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 2010;122(22):2254-63.
3. Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA. Racial differences in infant mortality attributable to birth defects in the United States, 1989- 2002. Birth Defects Res A Clin Mol Teratol 2006;76(10):706-13.
4. Lisowski LA, Verheijen PM, Copel JA, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz 2010;35(1):19-26.
5. Erickson JD. Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study. Teratology 1991;43(1):41-51.
6. Correa A, Gilboa SM, Botto LD, et al. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus associated birth defects. Am J Obstet Gynecol 2012;206(3):218 e1-e13.
7. Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008;199(3):237 e1-e9.
8. Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Periconception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 2012;55(4):936-47.
9. Ferencz C, Rubin JD, McCarter RJ, Clark EB. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 1990;41(3):319-26.
10. Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Def Res A Clin Mol Teratol 2005;73(9):605-11.
11. Reece EA, Homko CJ, Wu YK. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 1996;54(4):171-82.
12. Yang P, Zhao Z, Reece EA. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol 2008;198(1):130 e1-e7.
13. Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers - animal and human studies. Rev Endocr Metab Disord 2003;4(1):79-93.
14. Zhao Z, Reece EA. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions. J Soc Gynecol Investig 2005;12(8):549-57.
15. Kitzmiller JL, Wallerstein R, Correa A, Kwan S. Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol 2010;88(10): 791-803.
16. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Preconception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 1996;19(5):514-41.
17. Starikov R, Bohrer J, Goh W, et al. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol 2013;34(7):1716-22.
18. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 2006;6:30.
19. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001;94(8):435-44.
20. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009; 94(11):4284-91.
21. Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2010;10:63.
22. Casele HL, Laifer SA. Factors influencing preconception control of glycemia in diabetic women. Arch Intern Med 1998;158(12): 1321-4.
23. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998;21(6):889-95.
24. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29(6):1263-8.
25. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33(3):562-8.
26. Lawrence JM, Contreras R, Chen WS, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31(5):899-904.
27. Albrecht SS, Kuklina EV, Bansil P, et al. Diabetes trends among delivery hospitalizations in the US, 1994-2004. Diabetes Care 2010; 33(4):768-73.
28. CDC. National Center for Health Statistics. Health Data Interactive. www.cdc.gov/nchs/hdi.htm.
29. Razzaghi H, Marcinkevage J, Peterson C. Prevalence of undiagnosed diabetes among non-pregnant women of reproductive age in the United States, 1999-2010. Prim Care Diabetes 2013 Nov 8. pii: S1751-9918(13)00120-4. http://dx.doi.org/10.1016/j.pcd.2013.10.004. [Epub ahead of print].
30. Chung CS, Myrianthopoulos NC. Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations. Birth Defects 1975;11(10):23-38.
31. Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 2001;64(2):98-106.
32. Nielsen GL, Norgard B, Puho E, Rothman KJ, Sorensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabetic Med 2005;22(6):693-6.
33. Eidem I, Stene LC, Henriksen T, et al. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999-2004. Acta Obstet Gyn Scand 2010;89(11): 1403-11.
34. Peticca P, Keely EJ, Walker MC, Yang Q, Bottomley J. Pregnancy outcomes in diabetes subtypes: how do they compare? A provincebased study of Ontario, 2005-2006. J Obstet Gynaecol Can 2009;31(6): 487-96.
35. Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002;100(5 Pt 1):925-30.
36. Knight KM, Pressman EK, Hackney DN, Thornburg LL. Perinatal outcomes in type 2 diabetic patients compared with non-diabetic patients matched by body mass index. J Matern-Fetal Neonatal Med 2012;25(6):611-5.
37. Janssen PA, Rothman I, Schwartz SM. Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. Paediatr Perinat EP 1996;10(1):52-63.
38. Agopian AJ, Moulik M, Gupta-Malhotra M, Marengo LK, Mitchell LE. Descriptive epidemiology of non-syndromic complete atrioventricular canal defects. Paediatr Perinat Epidemiol 2012;26(6):515-24.
39. Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A 2010;88(12):1008-16.
40. Bjornard K, Riehle-Colarusso T, Gilboa SM, Correa A. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol 2013;97(2):87-94.
41. Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Mathews TJ. Births: final data for 2011. Natl Vital Stat Rep 2013;62(1):1-69, 72.
42. Velez Edwards DR, Likis FE, Andrews JC, et al. Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route. Arch Gynecol Obstet 2013;287(6):1059-66.
43. Gajic-Veljanoski O, Tomlinson G, Srighanthan J, et al. Effect of Odanacatib on BMD and fractures: estimates from Bayesian univariate and bivariate meta-analyses. J Clin Endocrinol Metab 2014;99(9): 3070-9.
44. National Center for Health Statistics. Health, United States, 2010: with special feature on death and dying. DHHS publ. no. 2011-1232. Hyattsville, MD: DHHS, CDC, 2011.
45. Coughlin SS, Benichou J, Weed DL. Attributable risk estimation in case-control studies. Epidemiol Rev 1994;16(1):51-64.
46. Vos T, Astbury J, Piers LS, et al. Measuring the impact of intimate partner violence on the health of women in Victoria, Australia. Bull World Health Organ 2006;84(9):739-44.
47. Land CE, Bouville A, Apostoaei I, Simon SL. Projected lifetime cancer risks from exposure to regional radioactive fallout in the Marshall Islands. Health Phys 2010;99(2):201-15.
48. Cheng YJ, Imperatore G, Geiss LS, et al. Secular changes in the agespecific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care 2013;36(9):2690-6.
49. Imperatore G, Boyle JP, Thompson TJ, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012;35(12):2515-20.
50. Garne E, Loane M, Dolk H, et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol 2012;94(3):134-40.
51. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328(7445):915.
52. Sibai BM, Caritis SN, Hauth JC, et al. Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of Child health and Human Development Maternal- Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183(6):1520-4.
53. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004;27(12):2819-23.
54. Howden LM, Meyer JA. Age and sex composition: 2010. U.S. Census Bureau, Census Briefs. 2011. www.census.gov/prod/cen2010/briefs/c2010br-03.pdf.
55. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 2004;27(Suppl 1):S76-S78.
56. Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: an Endocrine Society clinical practice guideline. J Clin Endocr Metab 2013;98(11):4227-49.
57. Xaverius PK, Salas J, Kiel D. Differences in pregnancy planning between women aged 18-44, with and without diabetes: behavioral risk factor surveillance system analysis. Diabetes Res Clin Pr 2013; 99(1):63-8.
58. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Womens Health Issues 2005;15(4):167-73.
59. Vahratian A, Barber JS, Lawrence JM, Kim C. Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey For Family Growth. Diabetes Care 2009;32(6):1026-31.
60. Chen R, Ben-Haroush A, Weismann-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007;197(4):404 e1-e5.
61. Executive summary: Standards of medical care in diabetes - 2013. Diabetes Care 2013;36(Suppl 1):S4-10.
62. Bell R, Bailey K, Cresswell T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008;115(4):445-52.
63. Fung A, Manlhiot C, Naik S, et al. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc 2013;2(3): e000064. http://dx.doi.org/10.1161/JAHA.113.000064.
64. Duong HT, Hoyt AT, Carmichael SL, et al. Is maternal parity an independent risk factor for birth defects? Birth Defects Res A Clin Mol Teratol 2012;94(4):230-6.